Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Johnson and Johnson
Merck
Boehringer Ingelheim
Argus Health
Julphar
Moodys
US Army
Healthtrust

Generated: February 24, 2018

DrugPatentWatch Database Preview

GLUCAGON Drug Profile

« Back to Dashboard

When do Glucagon patents expire, and when can generic versions of Glucagon launch?

Glucagon is a drug marketed by Lilly and Fresenius Kabi Usa and is included in three NDAs.

The generic ingredient in GLUCAGON is glucagon recombinant. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon recombinant profile page.

US Patents and Regulatory Information for GLUCAGON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly GLUCAGON glucagon hydrochloride INJECTABLE;INJECTION 012122-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa GLUCAGON glucagon hydrochloride POWDER;INTRAMUSCULAR, INTRAVENOUS 201849-001 May 8, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly GLUCAGON glucagon recombinant INJECTABLE;INJECTION 020928-001 Sep 11, 1998 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly GLUCAGON glucagon hydrochloride INJECTABLE;INJECTION 012122-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Cipla
Johnson and Johnson
Baxter
Queensland Health
QuintilesIMS
Cantor Fitzgerald
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot